Key Takeaways:
- Locus Fermentation Solutions has retained Hilco Global IP Services to seek buyers for more than 120 non-core patents and patent applications covering five technology areas.
- The patent portfolio spans animal nutrition, cement, health and pharma, food production, and textile printing and dyeing, with coverage across multiple global jurisdictions.
- The assets are available for acquisition in full or in part, with interested parties required to sign a non-disclosure agreement with Hilco Global before receiving further information.
- Locus Fermentation Solutions has shifted its strategic focus toward commercialisation of its core biosurfactant and fermentation technologies.
- The portfolio covers innovations developed over more than a decade of R&D investment, including technologies targeting greenhouse gas reduction, drug bioavailability, and industrial water usage.
Locus Fermentation Solutions Makes Non-Core Patent Portfolio Available for Purchase
Locus Fermentation Solutions, a biotech company based in Solon, Ohio, has engaged Hilco Global IP Services to manage the sale of more than 120 patents and patent applications that the company considers non-core to its current business direction. The portfolio is available for acquisition in its entirety or as individual segments by industry.
Locus Fermentation Solutions was founded over a decade ago with a focus on fermentation-enabled molecules and biosurfactants. In recent years, the company has narrowed its commercial focus and identified several technology areas it no longer intends to pursue directly.
What the Locus Fermentation Portfolio Covers
Animal Nutrition
The largest segment of the portfolio available from Locus Fermentation Solutions comprises more than 60 patents and applications across 14 jurisdictions in Asia, Europe, and North and South America. The technologies centre on the use of microbial compositions to improve animal health, feed efficiency, and environmental outcomes in agriculture and aquaculture.
